يعرض 1 - 10 نتائج من 60 نتيجة بحث عن '"Stella-Ascariz, Natalia"', وقت الاستعلام: 1.47s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: The Journal of Infectious Diseases, 2017 Nov . 216, S847-S850.

  4. 4
    دورية أكاديمية

    المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospital La Paz Institute for Health Research Madrid, Espagne, Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Germans Trias i Pujol University Hospital Badalona, Barcelona, Spain (GTPUH), Epidémiologie et Biostatistique Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospital del Mar Barcelone, Espagne, Service de Médecine Interne Suresnes, Hôpital Foch Suresnes, Institute of Health Carlos III, Infectious Diseases Department Nantes, Université de Nantes (UN), This work was supported by NEAT-ID Foundation (not for profit private foundation to promote research and education projects in the HIV field), Red Tematica Cooperativa de Investigacion en Sida, and Fondo de Investigaciones Sanitarias (supported by FEDER funds, grant number PI13/01467) The NEAT 001/ANRS 143 trial was supported by Gilead Sciences, Janssen Pharmaceuticals, and Merck Laboratories. French National Institute for Health and Medical Research–France Recherche Nord and Sud Sida-HIV Hepatites (Inserm-ANRS) was the sponsor and a founder of the trial., NEAT 001/ANRS 143 Trial Study Group

    المصدر: ISSN: 1932-6203.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32267847; inserm-02543732; https://inserm.hal.science/inserm-02543732Test; https://inserm.hal.science/inserm-02543732/documentTest; https://inserm.hal.science/inserm-02543732/file/journal.pone.0230772.pdfTest; PUBMED: 32267847; PUBMEDCENTRAL: PMC7141657

  5. 5
    دورية أكاديمية

    مصطلحات موضوعية: VIH (Virus), Farmacología, Sida

    العلاقة: Miguel, R. de, Rial-Crestelo, D., Domínguez-Domínguez, L., Montejano, R., Esteban-Cantos, A., Aranguren-Rivas, P., Stella-Ascariz, N., Bisbal, O., Bermejo-Plaza, L., García-Álvarez, M., Alejos, B., Hernando, A., Santacreu-Guerrero, M., Cadiñanos, J., Mayoral, M., Castro, J. M., Moreno, V., Martín-Carbonero, L., Delgado, R., … Arribas, J. R. (2020). Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO). EBioMedicine, 55, 102779. https://doi.org/10.1016/j.ebiom.2020.102779Test; http://hdl.handle.net/11268/9166Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المساهمون: NEAT-ID Foundation, Red Temática Cooperativa de Investigación en Sida, Fondo de Investigaciones Sanitarias, Gilead Sciences, Janssen Pharmaceuticals, Merck Laboratories, French National Institute for Health, Medical Research–France Recherche Nord and Sud Sida-HIV Hepatites (Inserm-ANRS)

    المصدر: The Journal of Infectious Diseases ; volume 218, issue 10, page 1523-1530 ; ISSN 0022-1899 1537-6613

    مصطلحات موضوعية: Infectious Diseases, Immunology and Allergy

  9. 9
  10. 10
    دورية أكاديمية